External validation of axoCellsTM ventricular cardiomyocytes against CiPA cardiotoxicity compound panel
In this application note we show that axoCells ventricular cardiomyocytes have applications for in vitro cardiac safety testing and detection of pro-arrhythmic risk of new compounds.